KRABEVA Bevacizumab (r-DNA Origin) Concentrate for Solution for Intravenous Infusion 25mg/mL
Registration Number: MAL20126007AZ
Approved
Approval ID
373dced4c2307925
Registration Number
MAL20126007AZ
Registration Date
Jul 7, 2025
Regulatory Authority
NPRA
MalaysiaProduct Information
Additional product specifications and packaging information as registered with NPRA Malaysia.
Product Specifications
PRODUCT SPECIFICATIONS
PACKAGING INFORMATION (1)
1 VialsAvailable
Package Size: 1 Vials
Status: NPRA Approved
Active Ingredients
Active pharmaceutical ingredients contained in this NPRA-approved product.
Ingredients (1)
BevacizumabActive
Monograph: 贝伐珠单抗